Occupe actuellement un poste chez Fate Therapeutics Inc
Position | Company | Period |
---|---|---|
Vice President - Clinical Devel | Fate Therapeutics Inc | 18 avril 2019 - |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2023-01-11 | 2023-01-10 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
7 825
-5.2%
5,2441 003 USD |
7 825 -5.2% | 5,24 | 41 003 USD | |
2022-04-21 | 2022-04-19 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
4 062
-2.6%
35,37143 673 USD |
4 062 -2.6% | 35,37 | 143 673 USD | |
2022-01-13 | 2022-01-11 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
418
-0.3%
49,1020 524 USD |
418 -0.3% | 49,10 | 20 524 USD | |
2022-01-13 | 2022-01-11 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
3 547
-2.8%
48,44171 817 USD |
3 547 -2.8% | 48,44 | 171 817 USD | |
2021-12-13 | 2021-12-10 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
5
-0.0%
55,54278 USD |
5 -0.0% | 55,54 | 278 USD | |
2021-12-13 | 2021-12-10 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
600
-0.5%
54,5832 748 USD |
600 -0.5% | 54,58 | 32 748 USD | |
2021-12-13 | 2021-12-10 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
1 031
-0.8%
53,6655 323 USD |
1 031 -0.8% | 53,66 | 55 323 USD | |
2021-12-13 | 2021-12-10 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
1 822
-1.4%
52,3795 418 USD |
1 822 -1.4% | 52,37 | 95 418 USD | |
2021-12-13 | 2021-12-10 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
1 045
-0.8%
51,0853 379 USD |
1 045 -0.8% | 51,08 | 53 379 USD | |
2021-12-13 | 2021-12-10 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
900
-0.7%
50,4245 378 USD |
900 -0.7% | 50,42 | 45 378 USD | |
2021-12-13 | 2021-12-10 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
2 097
-1.6%
49,32103 424 USD |
2 097 -1.6% | 49,32 | 103 424 USD | |
2021-04-20 | 2021-04-16 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
1 500
-2.3%
84,41126 615 USD |
1 500 -2.3% | 84,41 | 126 615 USD | |
2021-04-20 | 2021-04-16 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
900
-1.3%
82,9174 619 USD |
900 -1.3% | 82,91 | 74 619 USD | |
2021-04-20 | 2021-04-16 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
875
-1.3%
81,8071 575 USD |
875 -1.3% | 81,80 | 71 575 USD |